Benefect Botanical Disinfectants & Cleaners for the Insurance Restoration Industry


Does Benefect Kill Ebola?
posted on October 30, 2014 6:16 PM Benefect Kill Ebola_International.pdf

Ebola is a contagious deadly disease found primarily in Africa but isolated cases have recently been revealed in North America. Ebola is still expected to be a controllable public threat in North America where hygiene standards & health care systems are more advanced. The Ebola virus is an Enveloped Virus which is transmitted through direct contact with infected blood or body fluids/substances. Below is a collection of international interim guidance to assist the restorer in decision-making. Unfortunately, the guidance lacks some consistency in recommendations but does seem to be consistent in acknowledging that Ebola is not particularly tough to kill on surfaces.

Although Benefect nor any other disinfectant have been specifically tested against Ebola, based on the CDC disinfectant recommendations per Ebola (below) & their rankings of disinfectant potency (See chart in the link above), Benefect Decon 30 Disinfectant has efficacy against common Non-Enveloped Viruses such as Rhinovirus plus common Enveloped Viruses such as Influenza, H1N1. Benefect Broad Spectrum Disinfectant is an Intermediate-Level Tuberculocidal Hospital Disinfectant which is considerably more potent than what is normally required for an Enveloped Virus such as Ebola & has additional efficacy against the common Non-Enveloped Virus HIV.

The CDC specifically states that “although there are no products with specific label claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, Non-Enveloped Viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an Enveloped Virus is being recommended at this time.” (

The WHO (World Health Organization) Interim Guidance recommends “environmental surfaces or objects contaminated with blood, other body fluids, secretions or excretions should be cleaned and disinfected as soon as possible using standard hospital disinfectants/detergents (e.g. a 0.5% chlorine bleach solution)” (

Health Canada’s Interim Guidance on Ebola ( recommends “the label should have a ‘broad spectrum virucide’ claim and/or acknowledge effective testing against any of: Adenovirus type 5, Bovine Parvovirus, Canine Parvovirus or Poliovirus type 1.” All of these organisms are Non-Enveloped Viruses.

The EPA & Health Canada have not released any official guidance regarding Ebola claims for registered disinfectant manufacturers as of the date of this release. We are assured that they are working 24/7 reviewing their standards to come up with a surrogate claim for the marketplace during this time as they have done for H1N1 & SARS in the past.

Note: this is a semblance of publicly available interim guidance which is subject to change. Proper due diligence is advised.

< back to News page